Comparison 2. Usual care versus immunosuppressive withdrawal after combination therapy.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Relapse at 12 or 24 months	2	111	Risk Ratio (M‐H, Random, 95% CI)	1.02 [0.68, 1.52]
2 Adverse events	2	111	Risk Ratio (M‐H, Random, 95% CI)	1.11 [0.44, 2.81]
3 Serious adverse events	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected